To emerge as a leading player in manufacturing of APIs in the expectorant therapeutic category and achieve optimum growth in all areas of the organization by following transparency in operations at all levels of management and compliance with all the laws of the land, thereby creating optimum wealth to the investment of shareholders, government and all stakeholders who are contributing to the well being of the company.